However, the positive sorting method based on CTCs surface markers (EpCAM, EGFR and other surface markers) cannot obtain more representative tumor cells, resulting in missed selection of many cells with different molecular phenotypes, which has severely restricted the CTCs application value [18, 19]. The gene discussed is EPCAM; the disease is neoplasm.